| Patient | Ronald Reagan |
|---|---|
| Date of birth | 1936-02-06 |
| Identifiers | MRN HR-ML008-SYN; SSN (made up) 000-08-6047 |
| Document date | 2026-11-01 |
| Author | Margaret Ellison, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Primary care visit one month after right hip fracture repair, with dementia and caregiver assessment. Concerns: His spouse is afraid he will fall again, especially at night, and is exhausted; He wants to walk outdoors in the garden again and to stay at home. [S]
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Donepezil 10 mg oral tablet, one tablet by mouth daily in the morning | One tablet by mouth daily in the morning | Oral route | 2022-03-07 | active | S |
| Acetaminophen 500 mg oral tablet, two tablets (1,000 mg) by mouth three times daily | Two tablets by mouth three times daily | Oral route | 2026-01-14 to 2026-04-14 | completed | S |
| Oxycodone 5 mg oral tablet, one tablet by mouth every six hours as needed for severe pain | One tablet by mouth every six hours as needed for severe pain | Oral route | 2026-01-14 to 2026-02-10 | stopped | S |
| Diphenhydramine 25 mg oral capsule, one capsule by mouth at bedtime | One capsule by mouth at bedtime | Oral route | 2026-01-16 to 2026-02-10 | stopped | S |
| Enoxaparin 40 mg/0.4 mL prefilled syringe, inject 40 mg under the skin daily through day 35 after surgery | Inject 40 mg under the skin once daily | Subcutaneous route | 2026-01-14 to 2026-02-17 | completed | S |
| Cholecalciferol 50 mcg (2,000 units) oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 2026-02-10 | active | S |
| Zoledronic acid 5 mg/100 mL intravenous infusion over at least 15 minutes, once yearly | 5 mg intravenously over at least 15 minutes once a year; first dose given | Intravenous route | 2026-04-14 to 2026-04-14 | completed | S |
| Procedure | Dates | Status | Evidence |
|---|---|---|---|
| Internal fixation of right intertrochanteric hip fracture with a sliding hip screw and side plate | 2026-01-13 to 2026-01-13 | completed | S |
| Home safety assessment with occupational therapy | 2026-02-10 to 2026-02-10 | completed | S |
| Advance care planning conversation with the patient and his spouse | 2026-02-24 to 2026-02-24 | completed | S |
| Dual-energy X-ray absorptiometry of the left hip and lumbar spine: left total hip T-score -2.8, lumbar spine T-score -1.9 | 2026-04-14 to 2026-04-14 | completed | S |
| Date | Vaccine | Status | Evidence |
|---|---|---|---|
| 2025-10-08 | High-dose influenza vaccine, 2025-2026 season | completed | S |
| 2026-04-14 | Pneumococcal conjugate vaccine PCV20 | completed | S |
| 2026-10-13 | High-dose influenza vaccine, 2026-2027 season | completed | S |
Historical biography with true dates. These events are not part of the synthetic care timeline.
| Historical date | History | Evidence |
|---|---|---|
| 1981 | Gunshot wound in an assassination attempt in 1981 | D (CLM-0007) |
| 1985 | Operation for colon cancer in 1985; prostate and skin-cancer surgery in 1987 | D (CLM-0007) |
| September 1989 | Thrown from a horse on July 4, 1989; fluid on the brain found and removed surgically at the Mayo Clinic in September 1989 | D (CLM-0005) |
| November 5, 1994 | Alzheimer's disease announced in a public letter on November 5, 1994, after memory testing by his physicians | D (CLM-0003, CLM-0004) |
| January 12, 2001 | Fell at home and broke his right hip on January 12, 2001; surgical repair with a pin, plate, and screws on January 13, 2001 | D (CLM-0006) |
| Relative | Condition | Age at death | Evidence |
|---|---|---|---|
| father | Died of a heart attack on May 18, 1941 | D (CLM-0008) | |
| mother | Died on July 25, 1962, of complications of Alzheimer's disease, according to the Reagan Library | D (CLM-0009) | |
| brother | Died of heart failure on December 11, 1996 | D (CLM-0008) |
| Concern | Status | Evidence |
|---|---|---|
| His spouse is afraid he will fall again, especially at night, and is exhausted | active | S |
| He wants to walk outdoors in the garden again and to stay at home | active | S |
Most recent measures: Hemoglobin [Mass/volume] in Blood 13.7 on 2026-07-14; Sodium [Moles/volume] in Serum or Plasma 138 on 2026-04-14; Potassium [Moles/volume] in Serum or Plasma 4.4 on 2026-04-14; Creatinine [Mass/volume] in Serum or Plasma 1.08 on 2026-04-14; Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 63 on 2026-04-14; Glucose [Mass/volume] in Serum or Plasma 94 on 2026-04-14; Calcium [Mass/volume] in Serum or Plasma 9.4 on 2026-07-14; 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma 36 on 2026-04-14; Parathyrin.intact [Mass/volume] in Serum or Plasma 78 on 2026-02-10; Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 112 on 2026-04-14; Magnesium [Mass/volume] in Serum or Plasma 2 on 2026-02-10; Thyrotropin [Units/volume] in Serum or Plasma 2.3 on 2026-02-10; Total score [MoCA] 11 on 2026-02-10; Total score Barthel Index 85 on 2026-07-14; Geriatric depression scale (GDS) short version total 3 on 2026-07-14; DXA Hip - left [Mass/Area] Bone density 0.637 on 2026-04-14; Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 on 2026-10-13 [S]
Strengths and supports: Supports: spouse, adult children, a long-time aide, and church friends who visit [S]
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Alzheimer's disease with late onset, disclosed in 1994 | active | confirmed | G30.1 | S — Synthetic modern coding of the publicly disclosed diagnosis. |
| Dementia due to Alzheimer's disease, moderate (FAST stage 5), with evening restlessness | active | confirmed | F02.B0 | S — Synthetic stage; his actual stage at this age was not made public. |
| Osteoporosis with right hip fragility fracture after a fall at home, repaired with internal fixation; subsequent care | active | confirmed | M80.051D | S — Synthetic modern coding of the documented January 2001 hip fracture as an osteoporotic fracture; bone density and fracture pattern are synthetic. |
| Vitamin D deficiency | resolved | confirmed | E55.9 | S — Synthetic finding from the first-visit 25-hydroxyvitamin D; repleted by three months. |
| Acute blood loss anemia after hip surgery | resolved | confirmed | D62 | S — Synthetic postoperative finding; resolved by three months. |
| History of falling | active | confirmed | Z91.81 | S — Synthetic modern coding linked to the documented fall. |
| Personal history of colon cancer, operated on in 1985 | active | confirmed | Z85.038 | S — Synthetic modern coding of the documented 1985 operation. |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-02-10 | Hemoglobin [Mass/volume] in Blood | 11.1 | g/dL | 13.2-16.6 g/dL | Low | S |
| 2026-02-10 | Sodium [Moles/volume] in Serum or Plasma | 137 | mmol/L | 135-145 mmol/L | Normal | S |
| 2026-02-10 | Potassium [Moles/volume] in Serum or Plasma | 4.3 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2026-02-10 | Creatinine [Mass/volume] in Serum or Plasma | 1.12 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 2026-02-10 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 61 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 2026-02-10 | Glucose [Mass/volume] in Serum or Plasma | 96 | mg/dL | 70-99 mg/dL | Normal | S |
| 2026-02-10 | Calcium [Mass/volume] in Serum or Plasma | 9 | mg/dL | 8.6-10.3 mg/dL | Normal | S |
| 2026-02-10 | 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma | 16 | ng/mL | 30-100 ng/mL | Low | S |
| 2026-02-10 | Parathyrin.intact [Mass/volume] in Serum or Plasma | 78 | pg/mL | 15-65 pg/mL | High | S |
| 2026-02-10 | Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma | 134 | U/L | 40-129 U/L | High | S |
| 2026-02-10 | Magnesium [Mass/volume] in Serum or Plasma | 2 | mg/dL | 1.7-2.4 mg/dL | Normal | S |
| 2026-02-10 | Thyrotropin [Units/volume] in Serum or Plasma | 2.3 | m[IU]/L | 0.45-4.5 mIU/L | Normal | S |
| 2026-02-10 | Total score [MoCA] | 11 | {score} | S | ||
| 2026-02-10 | Total score Barthel Index | 55 | {score} | S | ||
| 2026-02-10 | Geriatric depression scale (GDS) short version total | 4 | {score} | S | ||
| 2026-02-24 | Total score Barthel Index | 60 | {score} | S | ||
| 2026-04-14 | Hemoglobin [Mass/volume] in Blood | 13.4 | g/dL | 13.2-16.6 g/dL | Normal | S |
| 2026-04-14 | Sodium [Moles/volume] in Serum or Plasma | 138 | mmol/L | 135-145 mmol/L | Normal | S |
| 2026-04-14 | Potassium [Moles/volume] in Serum or Plasma | 4.4 | mmol/L | 3.5-5.1 mmol/L | Normal | S |
| 2026-04-14 | Creatinine [Mass/volume] in Serum or Plasma | 1.08 | mg/dL | 0.74-1.35 mg/dL | Normal | S |
| 2026-04-14 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 63 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
| 2026-04-14 | Glucose [Mass/volume] in Serum or Plasma | 94 | mg/dL | 70-99 mg/dL | Normal | S |
| 2026-04-14 | Calcium [Mass/volume] in Serum or Plasma | 9.3 | mg/dL | 8.6-10.3 mg/dL | Normal | S |
| 2026-04-14 | 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Mass/volume] in Serum or Plasma | 36 | ng/mL | 30-100 ng/mL | Normal | S |
| 2026-04-14 | Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma | 112 | U/L | 40-129 U/L | Normal | S |
| 2026-04-14 | DXA Hip - left [Mass/Area] Bone density | 0.637 | g/cm2 | >=0.896 g/cm2 | Low | S |
| 2026-04-14 | Total score Barthel Index | 75 | {score} | S | ||
| 2026-04-14 | Geriatric depression scale (GDS) short version total | 3 | {score} | S | ||
| 2026-07-14 | Calcium [Mass/volume] in Serum or Plasma | 9.4 | mg/dL | 8.6-10.3 mg/dL | Normal | S |
| 2026-07-14 | Hemoglobin [Mass/volume] in Blood | 13.7 | g/dL | 13.2-16.6 g/dL | Normal | S |
| 2026-07-14 | Total score Barthel Index | 85 | {score} | S | ||
| 2026-07-14 | Geriatric depression scale (GDS) short version total | 3 | {score} | S | ||
| 2026-10-13 | Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] | 0 | {score} | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-02-10 | Body height | 185 | cm | S |
| 2026-02-10 | Body weight | 76 | kg | S |
| 2026-02-10 | Body mass index (BMI) [Ratio] | 22.2 | kg/m2 | S |
| 2026-02-10 | Systolic blood pressure | 128 | mm[Hg] | S |
| 2026-02-10 | Diastolic blood pressure | 70 | mm[Hg] | S |
| 2026-02-10 | Heart rate | 64 | /min | S |
| 2026-02-10 | Respiratory rate | 16 | /min | S |
| 2026-02-10 | Body temperature | 36.6 | Cel | S |
| 2026-02-10 | Oxygen saturation in Arterial blood by Pulse oximetry | 96 | % | S |
| 2026-02-24 | Body height | 185 | cm | S |
| 2026-02-24 | Body weight | 76.5 | kg | S |
| 2026-02-24 | Body mass index (BMI) [Ratio] | 22.4 | kg/m2 | S |
| 2026-02-24 | Systolic blood pressure | 126 | mm[Hg] | S |
| 2026-02-24 | Diastolic blood pressure | 72 | mm[Hg] | S |
| 2026-02-24 | Heart rate | 62 | /min | S |
| 2026-02-24 | Respiratory rate | 16 | /min | S |
| 2026-02-24 | Body temperature | 36.7 | Cel | S |
| 2026-02-24 | Oxygen saturation in Arterial blood by Pulse oximetry | 96 | % | S |
| 2026-04-14 | Body height | 185 | cm | S |
| 2026-04-14 | Body weight | 77.5 | kg | S |
| 2026-04-14 | Body mass index (BMI) [Ratio] | 22.6 | kg/m2 | S |
| 2026-04-14 | Systolic blood pressure | 130 | mm[Hg] | S |
| 2026-04-14 | Diastolic blood pressure | 72 | mm[Hg] | S |
| 2026-04-14 | Heart rate | 64 | /min | S |
| 2026-04-14 | Respiratory rate | 16 | /min | S |
| 2026-04-14 | Body temperature | 36.6 | Cel | S |
| 2026-04-14 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| 2026-07-14 | Body height | 185 | cm | S |
| 2026-07-14 | Body weight | 78 | kg | S |
| 2026-07-14 | Body mass index (BMI) [Ratio] | 22.8 | kg/m2 | S |
| 2026-07-14 | Systolic blood pressure | 128 | mm[Hg] | S |
| 2026-07-14 | Diastolic blood pressure | 70 | mm[Hg] | S |
| 2026-07-14 | Heart rate | 64 | /min | S |
| 2026-07-14 | Respiratory rate | 16 | /min | S |
| 2026-07-14 | Body temperature | 36.7 | Cel | S |
| 2026-07-14 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| 2026-10-13 | Body height | 185 | cm | S |
| 2026-10-13 | Body weight | 78.2 | kg | S |
| 2026-10-13 | Body mass index (BMI) [Ratio] | 22.8 | kg/m2 | S |
| 2026-10-13 | Systolic blood pressure | 126 | mm[Hg] | S |
| 2026-10-13 | Diastolic blood pressure | 70 | mm[Hg] | S |
| 2026-10-13 | Heart rate | 62 | /min | S |
| 2026-10-13 | Respiratory rate | 16 | /min | S |
| 2026-10-13 | Body temperature | 36.6 | Cel | S |
| 2026-10-13 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| Date | Purpose | Status | Provenance |
|---|---|---|---|
| 2026-02-10 | Primary care visit one month after right hip fracture repair, with dementia and caregiver assessment | finished | S |
| 2026-02-24 | Neurology consultation for Alzheimer's disease staging, medication review, and evening restlessness | finished | S |
| 2026-04-14 | Three-month post-fracture visit with bone density testing and zoledronic acid | finished | S |
| 2026-07-14 | Six-month post-fracture, dementia, and caregiver review | finished | S |
| 2026-10-13 | Subsequent annual wellness visit | finished | S |
| Intervention | Status | Guideline | Provenance |
|---|---|---|---|
| Stop oxycodone and diphenhydramine, keep acetaminophen scheduled, and finish 35 days of enoxaparin; review every medicine against the AGS Beers Criteria at each visit | completed | GL-BEERS-2023, GL-AAOS-HIP-2021, GL-CMID-2026 | S |
| Neurology consultation to stage the dementia, review donepezil benefit and its bradycardia and fall risk, and advise on evening restlessness without antipsychotics | completed | GL-ALZ-2024, GL-CMID-2026 | S |
| Home physical and occupational therapy, a home safety assessment, and a CDC STEADI fall-risk check at every visit | completed | GL-AAOS-HIP-2021, GL-CMID-2026 | S |
| Replete vitamin D, aim for 1,000 to 1,200 mg of calcium a day from food, then obtain DXA and give intravenous zoledronic acid at about three months once calcium and kidney function are checked | completed | GL-BHOF-2022, GL-CMID-2026 | S |
| Monitor dementia on the CMID schedule: yearly MoCA, FAST stage, and ADL and IADL scores; neuropsychiatric screen and depression screen at follow-up | completed | GL-CMID-2026, GL-ALZ-2024 | S |
| Support the caregiver: Zarit Burden Interview at the first and six-month visits, weekly respite, a home health aide, caregiver education, and Alzheimer's Association support services | completed | GL-CMID-2026, GL-ALZ-2024 | S |
| Advance care planning with the patient and spouse: confirm the health care agent, discuss goals of care, and complete a POLST form; revisit at each change in stage | completed | GL-CMID-2026, GL-ALZ-2024 | S |
| Goal | Target | Status | Outcome | Provenance |
|---|---|---|---|---|
| Walk household distances with a walker and supervision, with a Barthel Index of 75 or more, by the three-month visit | 2026-04-14 | completed | Barthel Index rose from 55 to 75; walks in the house and garden with a walker | S |
| 25-hydroxyvitamin D of 30 ng/mL or more by three months, then the first zoledronic acid infusion | 2026-04-14 | completed | 25-hydroxyvitamin D 36 ng/mL; zoledronic acid given | S |
| No further falls through the six-month visit | 2026-07-14 | completed | No falls; Timed Up and Go improved from 24 to 16 seconds | S |
| Lower the spouse's Zarit Burden Interview score by at least 10 points by six months | 2026-07-14 | completed | Zarit score fell from 41 to 27 with weekly respite, a home health aide, and caregiver education | S |
| Document a health care agent, goals of care, and a POLST form by the three-month visit | 2026-04-14 | completed | Health care agent confirmed and POLST completed with the patient and spouse | S |